Related Experiment Videos

Immunogenicity and cross-reactivity of syngeneic murine melanomas

C Donawho1, M L Kripke

  • 1Department of Immunology, University of Texas M.D. Anderson Cancer Center, Houston 77030.

Cancer Communications
|January 1, 1990
PubMed

Insights

Murine melanomas induced by carcinogens show unique cross-protective immunity. Unlike other skin cancers, these melanomas are highly immunogenic and protect against each other, suggesting unique tumor antigens.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Non-melanoma skin cancers are antigenic but rarely induce cross-protective immunity.
  • Melanocytic skin tumors' cross-reactivity in vivo remains largely uncharacterized.

Purpose of the Study:

  • To investigate the immunogenicity and in vivo cross-reactivity of chemically and ultraviolet-radiation-induced murine melanomas.
  • To compare the immune response elicited by melanomas versus non-melanoma skin cancers.

Main Methods:

  • Three distinct murine melanomas were induced using chemical carcinogens and/or ultraviolet radiation.
  • Tumor immunogenicity and cross-protective immunity were assessed using in vivo transplantation assays.
  • Comparison of immune responses between melanomas and non-melanoma skin cancers.

Main Results:

  • All three induced melanomas were highly immunogenic.
  • Each melanoma conferred a degree of protection against the others, indicating significant cross-reactivity.
  • Non-melanoma skin cancers induced by similar methods showed lower immunogenicity and lacked cross-protection against melanomas.

Conclusions:

  • Murine melanocytic tumors induced by carcinogens and UV radiation exhibit significant in vivo cross-reactivity.
  • This cross-reactivity distinguishes melanomas from other murine skin cancers.
  • Melanomas represent a unique subset of skin cancers with distinct immunological properties.

Related Concept Videos